BioNTech SE (NASDAQ: BNTX) reported Q1 EPS of (EUR1.73), EUR0.27 better than the analyst estimate of (EUR2.00). Revenue for the quarter came in at EUR182.8 million versus the consensus estimate of EUR204.08 million.

For earnings history and earnings-related data on BioNTech SE (BNTX) click here.